BUSINESS WIRE helps companies to disseminate their full text press releases, regulatory information and multimedia documents effectively and securely to news agencies, journalists, analysts and investors the world over.

Business Wire
06/02/2025 13:00
iFIT Expands Global Reach with Rollout of AI Coach in 19 Countries

iFIT Inc., a global leader in connected fitness and interactive content, today announced the expansion of its iFIT AI Coach (beta) across 19 countries: Australia, Austria, Belgium, Canada, Finland, France, Germany, Ireland, Italy, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, and the UK. This strategic expansion brings iFIT’s intelligent, personalized fitness technology to more athletes around the globe. AI Coach is iFIT’s most advanced digital tr...

06/02/2025 12:16
12BET Makes the Shortlist at the 2025 EGR Marketing & Innovation Awards

12BET, a pioneering name in the igaming world since 2007, is honored to be shortlisted in two categories at the 2025 EGR Marketing & Innovation Awards: Sportsbook Marketing Campaign, and Marketing Team of the Year – B2C. This recognition highlights the brand’s ongoing dedication to creating meaningful and original experiences that resonate with sports audiences and digital communities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/hom...

06/02/2025 12:00
Adtran expands Oscilloquartz atomic clock portfolio with lower-cost optical cesium solutions for wider market adoption

Adtran today launched the latest additions to its Oscilloquartz optical cesium portfolio, expanding access to precision timing across a wider range of network environments. The new OSA 3200 SP and OSA 3250 ePRC leverage advanced optical pumping technology, offering improved holdover, simplified maintenance and a typical lifetime of 10 years. Built on the same proven platform as Adtran’s high-end cesium models, the solutions enable telecom operators, data centers, power utilities and defense net...

06/02/2025 11:10
AngloGold Ashanti Agrees to the Sale of the Mineração Serra Grande Mine

AngloGold Ashanti plc (“AngloGold Ashanti”, “AGA” or the “Company”) has agreed to sell its interest in Mineração Serra Grande mine (“MSG”) located in the state of Goiás, Brazil, to Aura Minerals Inc. (“Aura”). The Company will sell Mineração Serra Grande S.A. (“Sale”), which owns MSG to a Brazilian incorporated affiliate of Aura (“Purchaser”) for the following consideration: A cash consideration of $76 million on closing subject to certain working capital adjustments as at the closing date...

06/02/2025 11:00
Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”

Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals. “We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Leno...

06/02/2025 11:00
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis

ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis. The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effecti...

06/02/2025 10:30
Lifezone Metals Files Initial Assessment for the Kabanga Nickel Project in Tanzania

Lifezone Metals Limited’s (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a hydrometallurgical refinery...

06/02/2025 10:00
Dole Advances Public-Private Partnerships to Expand Access to Essential Services for Agricultural Workers

Dole (NYSE: DOLE) today announced the signing of new public-private agreements to advance its award-winning Information and Wellbeing Centers (IWCs), a workplace-based initiative pioneered by Dole designed to deliver vital public and private services directly to the workplace, improving quality of life for agricultural workers in Costa Rica’s rural areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250602935679/en/A panel discuss...

06/02/2025 10:00
Corpay Cross-Border Named an Official Partner of Real Madrid C.F.

Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, is pleased to announce that Corpay’s Cross-Border business has entered into an agreement with Real Madrid C.F. to become an Official Partner. Through this partnership, Real Madrid will be able to gain access to and utilise Corpay Cross Border’s innovative solutions to help mitigate foreign exchange exposure from their day-to-day business needs. "The Corpay Cross-Border team is elated to be named an Official Partner of Real M...

06/02/2025 10:00
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, announced new clinical data from its emerging breast cancer pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Poster presentations feature preliminary results of the dose escalation studies of two investigational molecules: BG-C9074, a novel B7-H4-targeting antibody-drug conjugate (ADC) in patients with advanced solid tumors, including breast cancer, and BG-68501, a cyc...